4Nasr DM, Biller J, Rabinstein AA. Use and in-hospital outcomesof recombinant tissue plasminogen activator in pediatric arterial is-chemic stroke patients [ J ]. Pediatr Neurol,2014,51 (5 ) : 624-631.
5Cugno, M. Castelli, R. Bisiani, G. Anti-t-PA antibodies in acutemyocardial infarction after thrombolysis with rt-PA [ J ]. Eur J In-tern Med,2010’21 (1):25-29.
6Pieri A, Spitz M,Kihara EN, et al. Intra-arterial thrombolysisafter full-dose intravenous recombinant tissue plasminogen activa-tor for patients older than 80 years with acute ischemic stroke :what is the safety limit. [ J]. Neurol India, 2010,58(3) :487.
7Raju NC, Yi Q, Nidorf M, et al. Effect of colchicine comparedwith placebo on high sensitivity C-reactive protein in patients withacute coronary syndrome or acute stroke : a pilot randomized con-trolled trial[ J]. J Thromb Thrombolysis, 2012,33( 1) :88-94.
